Raymond James & Associates Has $2.04 Million Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Raymond James & Associates decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 45.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,467 shares of the medical instruments supplier’s stock after selling 17,253 shares during the quarter. Raymond James & Associates owned 0.08% of ICU Medical worth $2,041,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP grew its holdings in shares of ICU Medical by 71.6% in the 1st quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier’s stock worth $337,542,000 after purchasing an additional 632,609 shares during the last quarter. FMR LLC grew its holdings in shares of ICU Medical by 89.9% in the 3rd quarter. FMR LLC now owns 1,124,995 shares of the medical instruments supplier’s stock worth $133,886,000 after purchasing an additional 532,483 shares during the last quarter. Morgan Stanley grew its holdings in shares of ICU Medical by 233.5% in the 4th quarter. Morgan Stanley now owns 679,912 shares of the medical instruments supplier’s stock worth $107,073,000 after purchasing an additional 476,012 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in shares of ICU Medical by 59.2% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 1,015,006 shares of the medical instruments supplier’s stock worth $120,796,000 after purchasing an additional 377,532 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of ICU Medical by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier’s stock worth $472,466,000 after purchasing an additional 171,851 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Stock Down 0.8 %

Shares of NASDAQ:ICUI opened at $96.33 on Wednesday. ICU Medical, Inc. has a 12 month low of $78.28 and a 12 month high of $212.43. The company’s 50-day moving average price is $102.48 and its two-hundred day moving average price is $98.81. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. The firm has a market cap of $2.35 billion, a P/E ratio of -78.32 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. The firm had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. As a group, research analysts forecast that ICU Medical, Inc. will post 3.52 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, KeyCorp upped their target price on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a report on Wednesday, February 28th. One analyst has rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $123.00.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 13,603 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $107.19, for a total value of $1,458,105.57. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $107.19, for a total transaction of $1,458,105.57. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director George A. Lopez sold 7,978 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $101.87, for a total transaction of $812,718.86. Following the sale, the director now owns 877,343 shares in the company, valued at $89,374,931.41. The disclosure for this sale can be found here. Insiders have sold 24,262 shares of company stock worth $2,545,532 in the last ninety days. Company insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.